Curcumin Suppresses Proliferation and Migration of MDA-MB-231 Breast Cancer Cells through Autophagy-Dependent Akt Degradation

Abstract

Previous studies have evidenced that the anticancer potential of curcumin (diferuloylmethane), a main yellow bioactive compound from plant turmeric was mediated by interfering with PI3K/Akt signaling. However, the underlying molecular mechanism is still poorly understood. This study experimentally revealed that curcumin treatment reduced Akt protein expression in a dose- and time-dependent manner in MDA-MB-231 breast cancer cells, along with an activation of autophagy and suppression of ubiquitin-proteasome system (UPS) function. The curcumin-reduced Akt expression, cell proliferation, and migration were prevented by genetic and pharmacological inhibition of autophagy but not by UPS inhibition. Additionally, inactivation of AMPK by its specific inhibitor compound C or by target shRNA-mediated silencing attenuated curcumin-activated autophagy. Thus, these results indicate that curcumin-stimulated AMPK activity induces activation of the autophagy-lysosomal protein degradation pathway leading to Akt degradation and the subsequent suppression of proliferation and migration in breast cancer cell.

Skeletal Muscle Tissue Trib3 Links Obesity with Insulin Resistance by Autophagic Degradation of AKT2

“…We demonstrated that AKT2 turnover was strongly inhibited due to a block in the autophagy pathway, and consistent with our findings, some reports have suggested an association between AKT and autophagosome [45,46]. By using immunoprecipitation coupled with mass spectrometry, we observed the association of Trib3 with the autophagy receptors optineurin and p62 (data not shown), thus Trib3 may link AKT2 to an autophagosome.…”

APPL1-Mediating Leptin Signaling Contributes to Proliferation and Migration of Cancer Cells

“…MTT assay was performed as our previously described protocol [18, 19]. BrdU assay was carried out using BrdU Cell Proliferation Assay Kit (#6813, CST, Danvers, MA, USA) according to the manufacturer’s instructions.…”

PI3K/Akt/mTOR activation by suppression of ELK3 mediates chemosensitivity of MDA-MB-231 cells to doxorubicin by inhibiting autophagy

“…Recently, it was reported that activation of the autophagy-lysosomal degradation pathway induces degradation of Akt and subsequent suppression of the migration and proliferation of MDA-MB-231 cells [34]. This report suggests that the PI3K/Akt/mTOR pathway and autophagy form a regulatory loop.…”